A new study reveals that individuals taking weight-loss medications, such as Wegovy or Mounjaro, experience a decline in alcohol enjoyment and consumption. The research suggests these drugs could potentially aid in treating addiction.
A new study finds people who take weight-loss drugs also cut back on alcohol consumption . Researchers think the drugs could be a promising new treatment for addiction.iframe src="https://www.npr.org/player/embed/nx-s1-5205478/nx-s1-5275356-1" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
"I feel amazing," says Tamara Hall, 45, a mother of three. She began taking the GLP-1 drug Mounjaro in 2023 as part of a She noticed feeling full and dizzy after one drink, whereas before she felt she tolerated alcohol much better."The impact of the alcohol was more intense," she says, and so cutting back was easy."I didn't know it would have the impact of me not wanting the alcohol — so I think it's a huge benefit." She says the medication seems to cancel out the cravings..
"Maybe being enrolled in a weight management program encourages healthy behavior change," she says. This could be part of the explanation of the study findings.of Northwestern University, a GLP-1 researcher who is also a consultant to drug makers. People also reported less 'food noise' he says. Their"thinking of food diminished and the reward of food was diminished," Kushner says.
Obesity Drugs Weight Loss Alcohol Consumption Addiction Treatment Health Studies
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
How anti-obesity drugs are linked to food wasteTaking anti-obesity drugs has led some U.S. adults to throw away more food than they tossed before starting the medications, a new study has found.
Read more »
Stress and Obesity Could Be Linked, Study SuggestsObesity-related diseases such as type 2 diabetes may be caused by stress hormones.
Read more »
Obesity-Linked Heart Deaths Nearly Tripled in U.S. Over Past Two DecadesLives lost to obesity-related heart disease have nearly tripled over the past twenty years, a new study reports.
Read more »
Do Patients on Anti-Obesity Drugs Decrease Alcohol Use?Nearly half reported decreased drinking after initiating any anti-obesity medication, including second-generation GLP-1 receptor agonists.
Read more »
Drugmakers and pharmacists battle over who gets to make obesity drugsThe pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.
Read more »
Drugmakers and pharmacists battle over who gets to make obesity drugsThe pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from making cheaper copies. They argue they can keep up with demand on their own.
Read more »